NCT01415778View on ClinicalTrials.gov

Bioequivalence of ICI176,334-1 in Japanese Healthy Male Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

December 31, 2011

Conditions

Healthy

Interventions

DRUG

ICI176,334-1

Subject will receive single dose of ICI176,334-1

DRUG

Casodex 80 mg tablet

Subject will receive single dose of Casodex 80 mg tablet

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY